Reverse Enzyme Immunoassay for the Determination of Lolium perenne IgE Antibodies

1983 ◽  
Vol 72 (2) ◽  
pp. 184-187 ◽  
Author(s):  
M. Cuevas ◽  
I. Moneo ◽  
V. Ureña ◽  
J. Dominguez ◽  
A. Bootello
1983 ◽  
Vol 71 (3) ◽  
pp. 285-287 ◽  
Author(s):  
Ignacio Moneo ◽  
Manuela Cuevas ◽  
Victoria Ureña ◽  
Roberto Alcover ◽  
Alfredo Bootello

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 1083.2-1084
Author(s):  
O. Rusanova ◽  
A. Trofimenko ◽  
N. Emelyanov ◽  
O. Emelyanova

Background:Production of antibodies to ceruloplasmin (CP) in rheumatoid arthritis is an issue that has not been studied well enough. It was not by chance that this copper–containing alpha 2-glycorpoteid of blood plasma showing multienzymatic properties was chosen as an object of investigation. Data on the content and activity of CP in the blood of rheumatoid arthritis patients are contradictory, which has to do with different approaches to selection of patients and different measuring methods.Objectives:Improving diagnosis of rheumatoid arthritis by determination of antibodies to CP as well as its amount and enzymatic activity.Methods:We studied the serum from 30 apparently healthy individuals, and 108 rheumatoid arthritis patients. Antibodies to CP were determined by enzyme immunoassay using immobilized granulated antigen preparations (modification by Gontar et al, 2002). The amount of CP was determined by enzyme immunoassay according to the method of I.S. Kuzmina et al (1991) using commercial diagnostic agent manufactured by Mechnikov Research Institute for Vaccines and Sera.Results:Enzyme immunoassay showed a mean level of CP antibodies in donor sera of 0,020±0,006 optical density units. The level of normal values of specific antibodies determined as M±2σ included an extinction value in the range 0 – 0,086. The mean value of oxidase activity and the amount of CP in healthy people was 716±26,3 and 921±32 ng/ml, correspondingly. In the process of study we revealed a reliable increase in CP antibody count, the activity and amount of CP in patients with rheumatoid arthritis while in all cases the parameters under study correlated with the degree of disease activity (p<0,05): at activity degree I CP antibodies were 0,098±0,011; CP activity was 954±48,1; CP amount was 1292±73,4. At activity degree II CP antibodies were 0,138±0,007; CP activity was 1163±39,6; CP amount was 1763±69,3. At activity degree III, CP antibodies were 0,182±0,015; CP activity was 1368±89,5; CP amount was 1794±102,8. After a course of hospital treatment was completed, we noted a reliable decrease in the activity and amount of CP (at degree I of rheumatoid arthritis activity p<0,001, at degree II of rheumatoid arthritis activity p<0,01for both parameters; at degree III, p<0,05) compared with baseline findings. A decrease in CP antibodies shows decelerated dynamics, especially in patients with pronounced disease activity, which indicates severe disorders in the immunity that cannot be cured completely within 30 – 40 days of hospital treatment course.Conclusion:Determination of CP antibodies, as well as quantitative content of CP and its oxidase activity can serve as indicators of the activity of rheumatoid arthritis, as well as an accessory criterion of the effectiveness of administered therapy.Disclosure of Interests:None declared


2021 ◽  
pp. 104063872110435
Author(s):  
Valeria Pasciu ◽  
Maria Nieddu ◽  
Elena Baralla ◽  
Cristian Porcu ◽  
Francesca Sotgiu ◽  
...  

Determination of serum or plasma progesterone (P4) concentrations is important to recognize pregnant and non-pregnant ewes, and also to predict the number of carried lambs. The 2 most common methodologies for the detection of plasma P4 are radioimmunoassay (RIA) and enzyme immunoassay (EIA). RIA is very expensive, and not all laboratories are equipped to perform this test; EIA is commercially available for human use, but only a few companies produce species-specific kits, which are expensive. We verified for ovine plasma a less expensive and easily available ELISA kit (DiaMetra) designed to quantify P4 in humans. Pools of ovine and human plasma were used to compare repeatability, accuracy, sensitivity, and stability of P4 measured by the DiaMetra kit. Repeatability data were within 15%, and accuracy values were ~90% for both plasma matrices. Stability data showed a loss of <20% for freeze–thaw and <30% for 30-d storage. All parameters were acceptable under international guidelines for method validation. The human ELISA kit was used successfully to quantify plasma P4 in 26 ewes during pregnancy until delivery. P4 concentrations were also correlated with the number of carried lambs.


Author(s):  
T. S. Okuneva ◽  
M. V. Kushnareva ◽  
A. N. Pampura ◽  
E. E. Varlamov ◽  
N. G. Konyukova

We studied the frequency of occurrence and concentration of allergen-specific IgE antibodies (asIgE) to enterotoxins A, B, C and TSST-1 of Staphylococcus aureus and Malassezia spp. in the serum of children with atopic dermatitis in the acute period of the disease. The determination of asIgE levels was performed in 84 children aged from 5 months to 17 years using the immunochemiluminescent method on the UniCAP 100 analyzer (Phadia, Sweden). The level of asIgE was evaluated on a scale of 6 classes.The sensitization to S. aureus enterotoxins was detected in 29 children with аsIgE concentration from 0.35 to 25.8 kU/L (I–IV classes). In 16 children were observed 8 polysensitization options to S. aureus allergens. Combinations of asIgE to A + B and A + B + C enterotoxins were most common – in every fourth and fifth child,respectively. Sensitization to Malassezia spp. was observed in 41 children with concentration from 0.38 to 98.9 KU/L (I–V classes). Polysensitization to both S. aureus and Malassezia spp. allergens was observed in one of two children. A higher degree of sensitisation to Malassezia spp allergens has been established compared to S. aureus.Conclusion. To improve the specific diagnostics of atopic dermatitis, it is advisable to examine the serum for a complete panel of recombinant S. aureus enterotoxins in combination with the determination of asIgE to Malassezia spp. 


2007 ◽  
Vol 13 ◽  
pp. 399-402
Author(s):  
L. Blythe ◽  
C. Estill ◽  
J. Males ◽  
A.M. Craig

Perennial ryegrass (Lolium perenne) straw is used as a feed for livestock and horses. Some straw is infected with the endophyte, Neotyphodium lolii, which produces lolitrem tremorgens. Ingesting of the toxin produces clinical "ryegrass staggers." A 28 day feeding trail was conducted using 61 Black Angus, pure and crossbred cattle. The cattle were fed one of three levels of lolitrem B in chopped perennial ryegrass straw ranging from 0 ppb up to 3058 ppb. Four Japanese Wagyu crossbred cattle were fed chopped ryegrass straw containing 1400 ppb lolitrem B. The cattle were evaluated and scored twice a day for clinical signs of gait difficulties. Cattle consuming 1400 ppb lolitrem B did not show any overt clinical signs. After 14 days, 7 out of 15 cattle in the 1954 ppb lolitrem B group showed clinical signs of ataxia, stiffness, and tremors as seen in ryegrass staggers. All of the cattle in the positive control group of up to 3058 ppb lolitrem B with a 4 week mean of 2574 ppb developed clinical signs of staggers. None of the Wagyu cattle at 1400 ppb lolitrem B developed clinical signs. A dose response curve was developed based on the results of this study coupled with a prior study for use in the testing laboratory. Keywords: lolitrem B, perennial ryegrass, Lolium perenne, endophyte fungus, Neotyphodium lolii, cattle, threshold levels


Sign in / Sign up

Export Citation Format

Share Document